Applications Published 30 January 2002

Published: 1-Sep-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Orally immunogenic bacterial enterotoxins expressed in transgenic plants
    Boyce Thompson Institute for Plant Research; Mason, Hugh; Arntzen, Charles 1173144*

  • Method for reducing a susceptibility to tumour formation induced by 3-theoglucosone and precursors thereof
    Fox Chase Cancer Centre 1173155*

  • Folic acid supplement
    Drugtech Corp 1173203*

  • Aerosol formulations and devices for increasing libido in women via acute testosterone administration
    Aradigm Corp 1175204*

  • Inhibitors of crystallisation in a solid dispersion
    Abbott Laboratories 1175205*

  • Pharmaceutical compsns comprising apocodeine and/or its derivatives
    Unihart Corp 1175206*

  • Injection moulding method for (meth)acrylate copolymers having tertiary ammonium groups
    Roehm 1175207*

  • Compsns for preventing or treating dementia comprising a hydroxycinnamic acid derivative or an extract of a plant of genus Angelicae containing same
    Scigenic; Biosynergen 1175208*

  • Use of antiepileptics for treating respiratory disorders, in particular asthmatic disorders
    Lomia, Merab 1175209*

  • Increasing cerebral bioavailability of drugs
    Enos Pharmaceuticals 1175210*

  • Anticonvulsant derivatives useful in treating cocaine dependency
    Ortho-McNeil Pharmaceuticals 1175211*

  • Use of antioxidants to mitigate radioimmunotherapy-induced radiation toxicity
    Centre for Molecular Medicine and Immunology 1175212*

  • Heterocyclic aromatic compounds useful as growth hormone secretagogues
    Bristol-Myers Squibb 1175213*

  • Cyclooxygenase-2 inhibitor conpsns having rapid onset of therapeutic effect
    Pharmacia 1174214*

  • Use of osanetant in the production of medicaments used to treat mood disorders
    Sanofi-Synthelabo 1175215*

  • Antimalarial agents for the treatment of asthma
    APT Pharmaceutical 1175216*

  • (S)-benzoquinolizine carboxylic acids and their use as antibacterial agents
    Wockhardt 1175217*

  • Occular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-Beta
    The Schepens Eye Research Institute 1175218*

  • Treatment of bone cancer
    Mayo Foundation for Medical Education 1175219*

  • Nanoparticulate eplerenone compsns
    Pharmacia 1175220*

  • Lactic acid bacteria with anxiolytic properties and uses thereof
    Compagnie Gervais-Danone 1175221*

  • Monthly doses of glycopeptide antibiotics for treatment of Streptococcus pneumoniae infections
    Eli Lilly 1175222*

  • Methods and compsns for modulating an immune response
    Children's Medical Center 1175223*

  • Pegylated interferon Alfa-CCR5 antagonist combination HIV therapy
    Schering 1175224*

  • Elastin-based compsns
    The University of Utah Research Foundation 1175225*

  • Lipoglycan compsn and methods of treating parasitic infections
    University of Massachusetts 1175226*

  • Monoclonal antibody directed against cells of human renal cell carcinoma
    Centre National de la Recheche Scientifique 1175227*

  • Gene therapy using TGF-Beta
    Tissuegene 1175228*

  • 3,3'-substituted indoline derivatives
    American Home Products; Ligand Pharmaceuticals 1175397*

  • Indoline derivatives as progesterone antagonists
    American Home Products; Ligand Pharmaceuticals 1175398*

  • Renin inhibitors
    F Hoffmann-La Roche 1175400*

  • Piperazine derivatives useful as CCR5 antagonists
    Schering 1175401*

  • 6,7-disubstituted-5,8-quinolinedione derivatives as an antifungal agent
    Il Jin Copper Foil Co 1175403*

  • Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
    American Home Products; Ligand Pharmaceuticals 1175404*

  • Lactam inhibitors of FXA and method
    Bristol-Myers Squibb 1175405*

  • Imidazole derivatives as alpha-1A adrenoreceptor ligands
    Glaxo Group 1175406*

  • Pyrimidinone compounds
    SmithKline Beecham 1175408*

  • Pyrimidinones derivatives for the treatment of atherosclerosis
    SmithKline Beecham 1175409*

  • Cyclothoicarbamate derivatives as progesterone receptor modulators
    American Home Products; Ligand Pharmaceuticals 1175411*

  • Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
    Dr Reddy's Research Foundation 1175412*

  • Taxane formulations having improved solubility
    Florida State University Research Foundation 1175414*

  • Synthetic methods for preparing procyanidin oligomers
    Mars Inc 1175415*

  • Heterocyclic diazacycloalkanes, their preparation and use
    Neurosearch 1175416*

  • Substituted benzolactam compounds
    Pfizer 1175417*

  • Thiazolidinedione derivative and its use as antidiabetic
    SmithKline Beecham 1175418*

  • Aryl sulphones as factor XA inhibitors
    Du Pont Pharmaceuticals 1175419*

  • Process for preparing N8-substituted deaza-adenosine derivatives
    Aventis Pharma 1175420*

  • 9H-pyrimido[4,5-b]indole derivatives CRF1 specific ligands
    Neurogen 1175421*

  • Tetracyclic progesterone receptor modulators compounds and methods
    Ligand Pharmaceuticals; American Home Products 1175422*
  • You may also like